School of Medicine
Showing 1-78 of 78 Results
-
Masataka Wada
Postdoctoral Scholar, Psychiatry
BioDr. Masataka (he/him/his) is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.
His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Masataka is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.
Dr. Masataka's scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field. -
Grzegorz Walkiewicz
Postdoctoral Scholar, Ophthalmology
BioGrzegorz (Greg) Walkiewicz, PhD, is a neuroscientist with a strong background in retinal and neurodegenerative disease research. He completed his PhD at KU Leuven (Belgium), focusing on tau pathology and Alzheimer’s disease. His research explores the connection between brain and eye pathology, with particular interest in pTau, Aβ, and microglial activation. He has worked extensively with transgenic mouse models as well as human brain and retinal tissues. He recently joined Stanford University to investigate INPP5K-related mechanisms in retinal ganglion cell degeneration.
-
Bing Wang
Postdoctoral Scholar, Stem Cell Transplantation
BioMy academic training and research experience have equipped me with multidisciplinary skills and knowledge of molecular biology and immunology.
I led two projects when I was an undergraduate, in which I got primary academic learning. My team member and I investigated the bacteria content in drinking water from two types of machines that are commonly used in colleges under the guidance of our experimental microbiology teacher Zhihong Zhong. Secondly, we produced a hybridoma cell line secreting monoclonal antibody against the core antigen of the hepatitis C virus (HCV) to develop an ELISA kit for the detection of HCV under the guidance of Dr. Rushi Liu and Minjing Liao.
Thereafter, as a Ph. D. candidate at Xiaoming Feng’s lab, my research primarily focused on understanding the biology of regulatory T cells (Treg) and CD11c+ myeloid cells using cutting-edge single-cell sequencing and conditional knockout mice under healthy and disease conditions. We first revealed the heterogeneity and bifurcated differentiation pathway of human Tregs from normal donors and transplanted patients at the single-cell transcriptome level. A subsequent first and corresponding author publication identified a key innate responsive protein in CD11c+ alveolar macrophages, NRP2, that protects mice from lung injury via promoting the phagocytosis of neutrophils. I also participated in two projects regarding the role of a serine/threonine kinase, LKB1, in mice CD11c+ dendritic cells from lymphoid tissues and adipose tissue with diet-induced obesity. These academic experiences guided me into a strong passion and independent capacities for biomedical studies.
For my postdoctoral training, I will focus on developing Treg therapies and genetic stem cell therapy to cure patients with IPEX syndrome (a severe autoimmune disease) at preclinical and clinical stages, and other immune disorders. My sponsor Dr. Rosa Bacchetta is a well-known leader in treating IPEX patients and developing Treg therapies. My co-mentor Dr. Maria Grazia Roncarolo is a well-recognized pediatric immunologist and also one of the pioneers in the stem cell and gene therapy field, who discovered the type 1 regulatory T cells or Tr1 cells and translate the scientific discoveries into novel Treg therapies. Both of them have an excellent record of training postdoctoral fellows. The proposed projects will provide me with great opportunities in cutting-edge technology and translational research and outline a set of career development including grant writing, public presentation, and lab management, which will enhance my ability to become an independent investigator and help me to reach my goal of developing efficient and safe Treg therapies for a wide range of immune disorders and associated human diseases. -
Chong Wang
Postdoctoral Scholar, Radiology
BioI am currently a Postdoctoral Scholar in the Department of Radiology at Stanford University School of Medicine, affiliated with the Center for Artificial Intelligence in Medicine and Imaging (AIMI). My research mainly focuses on AI and foundation models in healthcare, with an emphasis on developing trustworthy, robust, and efficient AI solutions for medical imaging. I earned my Ph.D degree, honored with the Doctoral Research Medal, in Computer Science from the Australian Institute for Machine Learning (AIML), The University of Adelaide.
-
Jie Wang
Postdoctoral Scholar, Radiology
BioDr. Jie Wang is deeply passionate about magnetic nanotechnology, including magnetic resonance imaging (MRI), magnetic particle imaging (MPI), magnetic nanoparticles (MNPs), magnetic nanofluid hyperthermia (MNFH), magnetic biosensors, etc., for biomedical applications. His dissertation focuses on MRI-guided magnetic hyperthermia for cancer theranostics. Currently, his research interests include developing enzyme-activable nanoparticles for brain cancer theranostics and employing multi-modal imaging modalities to investigate the interaction between nanoparticles and biosystems (nano-bio interaction) within tumor microenvironment.
-
Kunyu Wang
Postdoctoral Scholar, Urology
BioKunyu Wang is a Postdoctoral Scholar in the Department of Urology at Stanford University School of Medicine. He received his Ph.D. from the University of Science and Technology of China in 2026 and his bachelor’s degree from Southeast University’s Chien-Shiung Wu College (Youth Class) in 2021.
His previous research experience includes multi-modal foundation models, embodied AI, and transfer learning. His current research centers on computational modeling for scientific discovery, with a particular focus on cancer biology. Using spatial omics data, he aims to uncover how cellular states, spatial organization, and cell–cell interactions shape cancer progression and treatment response. His long-term goal is to translate these insights into strategies for precision medicine and drug screening. -
Wenjun Wang
Postdoctoral Scholar, Stem Cell Transplantation
Current Research and Scholarly InterestsMy postdoctoral research focuses on investigating novel therapy for childhood leukemias.
-
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.
-
Yidan Wang
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioI joined Dr. John Benjamin’s lab to study the heterogeneity of neutrophils across developmental stages and during bronchopulmonary dysplasia (BPD). My research focuses on characterizing neutrophil subsets and investigating the contributions of distinct neutrophil subsets to the development of BPD.
My predoctoral training was completed at Northwestern University under the co-mentorship of Dr. Harris Perlman and Dr. Deborah Winter. I studied the heterogeneity and functions of monocyte-lineage cells and macrophages in mouse synovial tissue under both steady-state and inflammatory arthritis conditions. -
Yiyu Wang
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Yiyu Wang is a T32 postdoctoral researcher at the Department of Anesthesiology, Stanford School of Medicine. Her research combines computational models and neuroimaging techniques to characterize the neural architecture underlying complex human experiences in emotion and pain. Her current work focuses on leveraging deep learning, foundation models, and explainable AI to improve neuroimaging-based markers as well as multi-modal markers of chronic pain.
-
Yunyun Wang
Postdoctoral Scholar, Cardiovascular Medicine
BioYunyun is a postdoctoral scholar in Cardiovascular Medicine at Stanford. She received her PhD in Genetics from Zhejiang University in China (2025), where she studied the metabolic-epigenetic mechanisms of cardiovascular disease such as atherosclerosis and angiogenesis. In 2026, she joined the Quertermous Lab, where her research focuses on uncovering the mechanisms underlying atherosclerosis using Perturb-seq technology.
-
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Zongyi Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Chisondi S. Warioba, PhD
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioChisondi S. Warioba, PhD, is a Postdoctoral Scholar in the Division of Pain Medicine at the Stanford University School of Medicine, working in the Department of Anesthesiology, Perioperative and Pain Medicine with Dr. Sean Mackey and Dr. Kenneth Weber. His research develops machine learning and deep learning approaches for high-dimensional medical data, with an emphasis on cross-species translational neuroscience, resting-state fMRI, and multimodal MRI analysis (NODDI, DKI, and advanced diffusion techniques) to identify brain biomarkers of chronic pain.
He earned his PhD in Medical Physics from the University of Chicago, where his dissertation focused on cross-species mapping of functional connectivity alterations and therapeutic responses in hyperacute ischemic stroke. He completed a triple-major bachelor's degree in Chemistry, Physics, and Biology at Westmont College.
Dr. Warioba is a National Science Foundation Graduate Research Fellow and was awarded an Academic Visitor position at the University of Oxford's Department of Clinical Neurosciences. He received the Carl B. Allendoerfer Award from the Mathematical Association of America for expository excellence. He is committed to mentorship and community engagement, including STEM outreach for underrepresented students and neuroscience public education. -
Annika M. Weber
Postdoctoral Scholar, Gastroenterology
BioAnnika is a postdoctoral scholar in the Spencer Lab studying how gut microbes metabolize prebiotic fibers to produce bioactive metabolites linked to lowering disease risk. She holds an MS in Human Nutrition from the University of Sheffield and a PhD in Food Science and Human Nutrition from Colorado State University. Her work integrates multi-omic approaches to map diet-microbe-metabolite relationships. Annika aims to translate these mechanistic insights into microbiome-informed dietary strategies for reducing chronic diseases.
-
Ruolun Wei
Postdoctoral Scholar, Neurosurgery
BioRuolun Wei, MD, PhD, is a postdoctoral scholar in the Department of Neurosurgery at Stanford University. Dr. Wei’s work centers on neuro-oncology, with particular emphasis on brain tumor recurrence, treatment resistance, and tumor metabolism. He is also a board-certified neurosurgeon, currently focusing on full-time research. His research aims to bridge the gap between clinical practice and laboratory investigation, conducting translational research that moves from bedside to bench and back to bedside to improve therapeutic outcomes for patients with malignant brain tumors.
-
Alexis Thomas Weiner
Basic Life Research Scientist, Pathology Sponsored Projects
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Alexandre Raphael Wery
Postdoctoral Scholar, Hematology
Current Research and Scholarly InterestsAML. Measurable residual disease. Circulating tumor DNA. CAPP-Seq.
-
Philipp Wesp
Postdoctoral Scholar, Radiology
BioI am a postdoctoral researcher investigating interpretable machine learning (ML) and large language model (LLM) applications in clinical radiology. My current research focuses on two complementary areas: understanding what human-interpretable concepts self-supervised vision foundation models learn through mechanistic interpretability techniques like sparse autoencoders, and developing LLM-based systems, including agentic workflows and retrieval augmented generation (RAG) architectures, that leverage unstructured hospital data to improve radiological workflows. I earned my PhD from LMU Munich, where I focused on clinically motivated machine learning applications in medical imaging in the Department of Radiology.
My work is partially funded by a Walter Benjamin Fellowship from the DFG (German Research Foundation). -
McKenzie White
Postdoctoral Scholar, Radiology
BioI work at the intersection of machine learning, medical imaging, and biomechanics. I'm committed to developing tools that bridge gaps between computational methods, musculoskeletal research, and clinical care - enabling more precise analyses, efficient workflows, and improved surgical decision-making.
-
Shannon White
Postdoctoral Scholar, Genetics
BioHi, I'm Shannon White. I began my postdoctoral fellowship in Michael Snyder's lab in the fall of 2020. I received my PhD from Georgetown University in Tumor Biology in Chunling Yi's lab. My graduate worked explore the signaling and metabolic vulnerabilities of NF2-mutant tumors following YAP/TAZ depletion. My postdoctoral work is exploring the epigenetic hallmarks that contribute to colon cancer progression and drug resistance. I am developing colon organoids derived from pre-cancerous polyp tissue collected from Familial Adenomatous Polyposis patients as a model system to investigate epigenetic and signaling responses to chemoprevention treatments.
-
Lucy Whitmore
Postdoctoral Scholar, General Surgery
BioLucy Whitmore is a radiation physics researcher at Stanford University working on emerging radiotherapy technologies, with a particular focus on ultra-high dose-rate (FLASH) radiation delivery. Her research combines radiation dosimetry, preclinical irradiation, Monte Carlo simulation, accelerator physics, treatment planning, and quantitative analysis of radiation biology studies. She also works on very-high-energy electron beams, detector response, radiochromic film dosimetry, and the development of reproducible experimental and computational workflows for translational radiotherapy research.
-
Sara Wilkerson
Postdoctoral Scholar, Psychiatry
BioI am a postdoctoral fellow specializing in the treatment of OCD, anxiety and depressive disorders using a cognitive-behavioral framework. My research centers on the accurate assessment of internalizing disorders, as well as the etiology of anxiety and obsessive-compulsive disorders. I welcome "cold" emails for all professional inquiries.
-
Wesley Williams
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsFirstly, a goal of mine is to fashion a novel scatter-based parameter for PET reconstruction algorithms to improve image resolution via determining a more detailed scatter/true ratio estimate via binning the photons that have scattered once, twice, and perhaps, many more times.
Secondly, AI drug discovery application towards radiotracers may quicken experimentation by determining the formulations worth trying. Moreover, it may be able to characterize efficacy (biodistribution) (self-update). -
Emily Woods
Postdoctoral Scholar, Pathology
Current Research and Scholarly Interestsdevelopment of activity-based probes for specific diagnosis and treatment of Staphylococcus aureus infections and for detection of bacterial ear infections (otitis media)
-
Mulate Zerihun Workeneh
Postdoctoral Scholar, Critical Care
BioDr. Mulate Zerihun Workeneh is a Postdoctoral Scholar in Dr. Bereketeab Haileselassie’s laboratory in the Department of Pediatrics at Stanford University School of Medicine. He earned a Ph.D. in Medical Sciences from the Azrieli Faculty of Medicine at Bar-Ilan University, Israel, where he developed peptide therapeutics that target mitochondrial protein-protein interactions involved in cardiovascular disease. Dr. Workeneh’s research uses medicinal chemistry, chemical biology, peptide engineering, computational modeling and mitochondrial biology to understand how the disease occurs and to develop new ways to treat it. During his doctoral training, he designed and evaluated novel linear and macrocyclic peptide inhibitors that alter mitochondrial dynamics to mitigate mitochondrial dysfunction and cardiovascular injury. His work at Stanford is focused on defining the role of mitochondrial dynamics in endothelial dysfunction in sepsis and multiple organ dysfunction syndrome (MODS). He is working to develop peptide-based therapeutics that maintain mitochondrial function, improve vascular health and prevent organ failure in critically ill patients by integrating approaches in chemical biology, molecular and cellular biology, and translational drug discovery. Dr. Workeneh has publications in leading medicinal chemistry, pharmacology, and mitochondrial biology journals and is an inventor on patents related to mitochondrial protein-protein interaction inhibitors. His goal is to translate advances in mitochondrial biology into first-in-class therapeutics for cardiovascular disease, sepsis, and other disorders linked to mitochondrial dysfunction. He is excited to work across disciplines at Stanford to help push biomedical research forward.
-
Caren Yu-Ju Wu
Postdoctoral Scholar, Neurosurgery
Current Research and Scholarly InterestsBasic, translational, immunological and clinical research
-
Xiaozhuo Wu
Postdoctoral Scholar, Cardiothoracic Surgery
BioXiaozhuo (Chelsea) Wu holds a PhD in Biomaterial Engineering from the University of Manitoba, specializing in extracellular matrix scaffolds and computational simulations. Prior to her doctoral research, she earned degrees in mechanical and environmental engineering, bringing a multi-disciplinary perspective to her work. Her background integrates biomaterials mechanics with data science and clinical analytics. Outside of the lab, she enjoys hands-on making and crafting.
-
Yue Wu
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsI built computational methods to integrate and model biological time series, including metabolic dynamics, longitudinal multi-omics data, and micro-sampling. I reduce dimensions, built clusters, and search for causal links.
-
Ziyan Wu
Postdoctoral Scholar, Otolaryngology - Head & Neck Surgery
BioZiyan’s PhD research centers around contaminant sensing in the environment using Raman spectroscopy, membrane sensors, and machine learning. At Stanford, Ziyan will continue her research on investigating the health impacts of emerging contaminants.
